AtriCure Board Member Sold $143K In Company Stock
AtriCure, Inc. (ATRC) Presents at 2026 UBS Global Healthcare Conference Transcript
AtriCure: A New Quality Metric Could Put A Clip In Nearly Every Sternotomy
Is AtriCure (ATRC) Fully Valued After Strong Results And Raised 2026 Guidance?
Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $67
AtriCure (ATRC) Q3 2026 Earnings Call Transcript
Piper Sandler Reiterates Overweight on AtriCure, Raises Price Target to $70
AtriCure Analysts Boost Their Forecasts After Better-Than-Expected Q3 Results
Needham Maintains Buy on AtriCure, Raises Price Target to $70
BTIG Maintains Buy on AtriCure, Raises Price Target to $70
AtriCure, Inc. (ATRC) Q3 2026 Earnings Call Transcript
What AtriCure (ATRC) Said on Its Q3 Earnings Call
AtriCure (NASDAQ:ATRC) Q3 2026 Earnings: EPS Beat, Revenue Inline, Soft Guidance Weighs on Shares
Compared to Estimates, AtriCure (ATRC) Q3 Earnings: A Look at Key Metrics
AtriCure (ATRC) Beats Q3 Earnings and Revenue Estimates
AtriCure: Q3 Earnings Snapshot
AtriCure Reports Third Quarter 2026 Financial Results
AtriCure Q3 2026 Earnings Call Transcript
AtriCure Q3 Adj. EPS $0.17 Beats $(0.05) Estimate, Sales $154.450M Beat $151.217M Estimate
AtriCure Raises FY2026 GAAP EPS Guidance from $0.05-$0.13 to $0.21-$0.27 vs $0.14 Est
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.